Q2 2024 Matinas BioPharma Holdings Inc Earnings Call Transcript
Welcome to the Matinas BioPharma second-quarter 2024 financial results conference call. (Operator instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to Jody Cain. Please go ahead.
This is Jody Cain with LHA. Thank you for participating in today's call. Joining me from Matinas BioPharma are Jerome Jabbour, Chief Executive Officer, and Keith Kucinski, Chief Financial Officer; Dr. Theresa Matkovits, Chief Development Officer, and Dr. Terry Ferguson, Chief Medical Officer, will be available during the question and answer session.
I'd like to remind listeners that remarks made during this call may state management's future intentions hopes, beliefs, expectations or projections. These are forward-looking statements that involve risks and uncertainties. Forward-looking statements made pursuant to the safe harbor provisions of federal securities laws.
These forward-looking statements are based on current expectations and actual results
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |